No other cytokines or cancer markers, such as MCP‐1 (monocyte chemotactic protein‐1), GM‐CSF (granulocyte macrophage colony‐stimulating factor), IGF‐II, exhibited differences between the prostate disease groups and the normal healthy group (data not shown). This evidence concerns the gene CCL2 and cancer.